Public Relations

Live from Facebook! It’s Your Friendly Pharma Company

“Live.” It’s a word that can send a shudder through any pharma marketer, but ...

What I Learned from LISTENING to Reporters

Bernard M. Baruch, famed financier, political consultant, and philanthropist, once noted, “Most of the ...

Which Comes First: Trust or User Experience?

For anyone who has been a patient—or cared for one—finding trustworthy information online is ...

If Science Can Evolve, Why Can’t, or Isn’t, Pharma Marketing?

While new treatments focusing on personalized medicine, biosimilars, and targeting specific proteins have come ...

Media Firestorm Surrounds Oncology Communications

For decades now, the price of prescription drugs has been the subject of heated ...

Reaffirmed ACA Shifts Business as Usual

Regardless of how health executives called the recent King v. Burwell coin toss, the ...

Brand Equity Over Bottom Line?

Returning from Cannes Lions Health, I can officially say I’m inspired: The campaigns were ...

Millennials: The New “Boom” in Healthcare Marketing

Anyone will tell you the “sweet spot” of pharma marketing resides with those consumers ...

The Important Role of Advocacy in Keeping Care Before Cost

Connecting with patients and groups representing their therapeutic and psychosocial needs has long been ...

By the Patients, For the Patients

In 1786, Thomas Jefferson wrote, “Who then can so softly bind up the wound ...

If You Build It—They Will Come!

Field of Dreams remains the classic movie that continues to spark creative imagination. “If ...

The Difficult Art of Restraint

This is a time when biopharma brands are structured around integrated communications in order ...

Open the New Health Customer Floodgates

Whatever you think of the Affordable Care Act (ACA), from website snags to promise ...